# FDA Inspection 1209473 - Biomat USA, Inc. - June 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/fbe7887d-9d10-4b24-bb7c-d5bd10d8dc32
Source feed: FDA_Inspections

> FDA Inspection 1209473 for Biomat USA, Inc. on June 29, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209473
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-06-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1014009 - 2017-05-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cf3b478d-dc36-4293-ae37-0fe3a31f1254)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fae85f7e-a56f-487d-bd90-9cebadc9130c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d